JPRN-UMIN000048380已完成未知
Resarch of the effect of antiviral drugs on the suppression of COVID-19 persistent symptoms - Resarch of the effect of antiviral drugs on the suppression of COVID-19 persistent symptoms
agasaki University0 个研究点目标入组 382 人开始时间: 2022年7月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 382
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Patients diagnosed with moderate or severe COVID-19 at the time of first visit (2) Patients diagnosed with COVID-19 during hospitalization (3) Patients with COVID-19 who were started on antiviral drugs during hospitalization (4) Other patients deemed inappropriate as research subjects by the investigators.
研究者
相似试验
已完成
不适用
Investigation of antiviral treatment for symptomatic congenital cytomegalovirus infectioCongenital cytomegalovirus infectionJPRN-UMIN000019464Department of Pediatrics, Nagoya University Graduate School of Medicine20
进行中（未招募）
1 期
A Phase III Study of the Safety and Efficacy or Entecavir in Pediatric Patients with Chronic HBV-InfectioCHRONIC HEPATITIS B VIRUS,PEDIATRICMedDRA version: 14.1Level: PTClassification code 10008910Term: Chronic hepatitis BSystem Organ Class: 10021881 - Infections and infestationsEUCTR2009-016357-17-BEBristol-Myers Squibb International Corporation180
已完成
3 期
Comparative study in childrens with chronic Hepatitis B virus infection who are HBeAg positive.CTRI/2011/09/002001The pharmaceutical company sponsoring this study is BristolMyers Squibb180
进行中（未招募）
1 期
A Comparative Study of the Antiviral Efficacy and Safety of Entecavir (ETV) versus Placebo in Pediatric Subjects with Chronic Hepatitis B Virus (HBV) Infection who are HBeAg-PositiveCHRONIC HEPATITIS B VIRUS,PEDIATRICMedDRA version: 12.1Level: LLTClassification code 10008910Term: Chronic hepatitis BEUCTR2009-016357-17-GRBristol-Myers Squibb International Corporation257
进行中（未招募）
不适用
A Comparative Study of the Antiviral Efficacy and Safety of Entecavir Plus Tenofovir versus Adefovir Added to Continuing Lamivudine in Adults with Lamivudine Resistant Chronic Hepatitis B Virus Infection. - NDHepatitis B VirusMedDRA version: 9.1Level: LLTClassification code 10008910Term: Chronic hepatitis BEUCTR2007-001269-14-ITBRISTOL-M.SQUIBB84